| Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Holroyd E.W., Delacroix S., Larsen K., Harbuzariu A., Psaltis P.J., Wang L., Pan S., White T.A., Witt T.A., Kleppe L.S. et al.
Arterioscler. Thromb. Vasc. Biol. 32:704-711(2012) · Mapped (3) |
| Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis. White T.A., Johnson T., Zarzhevsky N., Tom C., Delacroix S., Holroyd E.W., Maroney S.A., Singh R., Pan S., Fay W.P. et al.
Blood 116:1787-1794(2010) · Mapped (7) |
| Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development. Pan S., White T.A., Witt T.A., Chiriac A., Mueske C.S., Simari R.D.
Circ. Res. 105:713-20, 8 p following 2009:720-720(2009) · Mapped (16) |
| Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension. White T.A., Witt T.A., Pan S., Mueske C.S., Kleppe L.S., Holroyd E.W., Champion H.C., Simari R.D.
Am. J. Respir. Cell Mol. Biol. 43:35-45(2010) · Mapped (3) |
| Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. Maroney S.A., Ferrel J.P., Pan S., White T.A., Simari R.D., McVey J.H., Mast A.E.
J. Thromb. Haemost. 7:1106-1113(2009) · Mapped (3) |
| Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Harrington S.C., Simari R.D., Conover C.A.
Circ. Res. 100:1696-1702(2007) · Mapped (22) |
| Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Resch Z.T., Simari R.D., Conover C.A.
Endocrinology 147:5634-5640(2006) · Mapped (1) |
| Blockade of human immunodeficiency virus type 1 expression by caveolin-1. Llano M., Kelly T., Vanegas M., Peretz M., Peterson T.E., Simari R.D., Poeschla E.M.
J. Virol. 76:9152-9164(2002) · Mapped (6) |
| The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. Rust C., Karnitz L.M., Paya C.V., Moscat J., Simari R.D., Gores G.J.
J. Biol. Chem. 275:20210-20216(2000) |
